Products

ExxonMobil PP Homopolymer PP1605MED

    • Product Name: ExxonMobil PP Homopolymer PP1605MED
    • Factroy Site: Yudu County, Ganzhou, Jiangxi, China
    • Price Inquiry: admin@ascent-chem.com
    • Manufacturer: Ascent Petrochem Holdings Co., Limited
    • CONTACT NOW
    Specifications
    HS Code 130819
    Density 0.9 g/cm³
    Melt Flow Rate Mfr 12 g/10 min at 230°C/2.16 kg
    Tensile Strength At Yield 34 MPa
    Elongation At Yield 12%
    Flexural Modulus 1400 MPa
    Notched Izod Impact Strength 3 kJ/m²
    Heat Deflection Temperature Hdt 100°C at 0.45 MPa
    Vicat Softening Temperature 150°C
    Rockwell Hardness R100
    Typical Processing Temperature 180-230°C

    As an accredited ExxonMobil PP Homopolymer PP1605MED factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing ExxonMobil PP Homopolymer PP1605MED is packaged as virgin resin pellets in sealed 25 kg polyethylene-lined paper bags, palletized and shrink-wrapped.
    Container Loading (20′ FCL) Load 20′ FCL with palletized ExxonMobil PP Homopolymer PP1605MED, securely braced and protected to ensure safe transit.
    Shipping ExxonMobil PP Homopolymer PP1605MED is a medical-grade polypropylene resin. Ship as a non-hazardous material in clean, dry containers or hopper railcars. Protect from moisture, contamination, and excessive heat. Store in original packaging away from direct sunlight. Follow standard polymer handling procedures to ensure safe, efficient transport.
    Storage Store in a cool, dry, well-ventilated area away from direct sunlight, heat, and open flames. Keep containers tightly sealed to prevent contamination and moisture pickup. Avoid prolonged UV exposure and store away from strong oxidizing agents. Maintain stable temperatures to preserve material properties and ensure safe handling.
    Shelf Life Shelf life is typically 12 months from shipment when stored unopened in original packaging, in a cool, dry area away from sunlight.
    Application of ExxonMobil PP Homopolymer PP1605MED

    In thermal cycling consumables the limiting variable is not melt temperature but crystallinity uniformity across a 0.20–0.25 mm sidewall. PP1605MED is a homopolymer polypropylene medical grade with nominal melt mass-flow rate of 16 g/10 min under ISO 1133-1:2022 and density of 0.900 g/cm³ under ISO 1183-1:2019. The resin is injection molded on 64-cavity and 96-cavity hot-runner tools for 384-well PCR plates, 8-strip tubes, and optical assay plates. Melt temperature is held at 220–235°C; mold temperature is maintained at 15–25°C. Injection velocity is set at 300–450 mm/s to prevent premature freeze-off at the gate. Switchover from velocity to pressure control occurs at 95% of filled volume, then holding pressure is applied at 40–60 MPa with residual cooling time of 4–7 s. Cavity pressure sensors are used as alarm limits; variation above 80 bar across cavities indicates valve-gate hesitation or blocked hot-runner tips. The practical melt-temperature control band is ±5°C around 230°C. Excursions above 235°C produce visible gate blush in valve-gated 384-well plates; excursions below 225°C increase short-shot frequency in the 0.20 mm sidewall. Compliance documentation for diagnostic consumables includes cytotoxicity per ISO 10993-5:2009 with L929 fibroblast cells and sensitization per ISO 10993-10:2021. The additive package excludes erucamide and silicone-based slip agents because these migrate to the surface and interfere with qPCR fluorescent signal acquisition. Sodium benzoate nucleation at 0.05–0.10 wt% increases crystallization temperature and reduces cycle time. Terminal components are real-time PCR plates, qPCR strip tubes, and 96-well assay frames. For bottom-read optical clarity, the homopolymer translucency is a boundary condition; clarified random copolymer or a film insert is required where transmitted light through a 1.0 mm wall must exceed 90%.

    How Does Radiation Sterilization Constrain Additive Selection in Syringe Component Molding?

    Single-use syringe plunger rods, tip closures, and two-piece plunger bodies are molded from PP1605MED on electric toggle-clamp injection machines with clamp force between 500 kN and 1,200 kN. Typical screw L/D ratio is 22:1 to 24:1 with compression ratio 2.2:1 to 2.5:1. Barrel zone settings follow 210°C/220°C/230°C/230°C, with hot-runner manifold at 235°C and mold coolant at 10–18°C. The critical conflict in this application is radiation sterilization. Gamma exposure at 25 kGy per ISO 11137-2:2013 induces chain scission and oxidative degradation in homopolymer polypropylene. To retain post-sterilization mechanical function, the grade is stabilized with a hindered phenolic primary antioxidant at 0.08–0.12 wt% and a phosphite secondary antioxidant at 0.10–0.15 wt%. Where cumulative absorbed dose exceeds 25 kGy or where product is double-sterilized, thioether synergist addition of 0.05–0.10 wt% is used; however, published data for this specific configuration is limited, so port-level tensile testing after aging at 60°C for 30 days is required per ISO 527-2:2012. Ethylene oxide sterilization is an alternative but requires residual validation. Ethylene oxide is absorbed by the polypropylene matrix and must be aerated at 50–55°C for 12–24 h to meet limits in ISO 10993-7:2008. Terminal products are syringe plunger rods and tip closures. PP1605MED is not recommended for transparent prefillable syringe barrels because homopolymer haze at 1.0 mm wall thickness typically remains above 15%; clarified random copolymer or cyclic olefin polymer is used for that component.

    Table 1 summarizes representative injection molding process windows for PP1605MED across the molded configurations described in this section.

    ConfigurationMelt temperatureMold temperatureInjection velocityHolding pressure
    384-well PCR plate220–235°C15–25°C300–450 mm/s40–60 MPa
    Syringe plunger rod220–240°C10–18°C120–250 mm/s45–55 MPa
    Rigid pharmaceutical closure220–240°C20–30°C80–150 mm/s45–55 MPa
    Inhaler actuator body225–240°C20–30°C180–300 mm/s40–50 MPa
    Diagnostic cassette215–235°C15–25°C150–250 mm/s35–45 MPa

    Inside the Autoclave Cycle: Wall Section Design and Cooling Uniformity in Rigid Closures

    Rigid screw closures for oral liquid bottles and infusion bottle caps are injection molded from PP1605MED and then subjected to steam sterilization at 121°C for 30 min. Under ISO 75-2:2013 method B at 0.45 MPa load, unmodified homopolymer PP heat deflection temperature is in the range 92–95°C, so residual hoop stress in an internally threaded closure must be minimized. The root of the thread is designed with a minimum radius of 0.30 mm, and the nominal wall is held at 2.0–2.5 mm to prevent excessive stress relaxation during the autoclave vacuum-pressure pulses. Tooling uses beryllium-copper core pins and conformal cooling channels; mold temperature is set to 20–30°C to achieve a uniform skin layer. Melt temperature is 220–240°C with back pressure 4–7 MPa. Holding pressure is 45–55 MPa for 2.0–2.5 s. Cycle time for a 28 mm closure with 2.0 mm sidewall is typically 8–12 s. A slip additive is incorporated at 0.05–0.15 wt% only in closures where torque release below 0.6 N·m is required on automated capping lines; for parenteral screw caps, slip additive is omitted to avoid extractables. Compliance for rigid closures includes USP <87> cytotoxicity and USP <88> Class VI biological reactivity for plastics, supported by ISO 10993-5:2009. Terminal products are 28 mm tamper-evident oral liquid closures, 38 mm infusion bottle screw caps, and 45 mm powder transfer caps.

    Because metered-dose inhaler actuators rely on snap-fit retention of the aluminium canister stem, dimensional variation across ejection must be held below 0.05 mm on critical latch features. PP1605MED is molded into 32-cavity cold-runner tools for MDI actuator bodies, dose counter wheels, and gear trains. Melt temperature is 225–240°C; mold temperature is 20–30°C; injection velocity is 180–300 mm/s; hold pressure is 40–50 MPa. The material is pigmented with carbon black at 0.2–0.5 wt% or titanium dioxide at 0.5–1.0 wt% for opaque housings. No plasticizer is present. Compliance includes USP <661.1> for plastic packaging systems and RoHS Directive 2011/65/EU Annex II with each restricted substance below 0.1 wt% in homogeneous material. Coefficient of dynamic friction against acetal gear teeth is evaluated on a rotary tribometer; values against POM typically range 0.30–0.40, but lot-to-lot variance from pigment dispersion must be monitored through process capability studies requiring Cpk ≥1.33 on latch width. Terminal products are actuator bodies, dose counter wheels, and snap-fit mouthpiece covers.

    When Diagnostic Cassette Bodies Are Exposed to Ethanol-Based Reagents and Cold-Chain Storage

    Polypropylene homopolymer absorbs less than 0.05 wt% moisture at 23°C and withstands intermittent contact with ethanol, isopropanol, and phosphate-buffered saline, but stress cracking may develop when non-ionic surfactants are present under snap-fit assembly strain. Microfluidic cassette bodies, lateral flow device housings, and immunoassay cartridge frames are molded from PP1605MED because the 16 g/10 min melt mass-flow rate allows long flow paths in thin rectangular parts without excessive orientation. Melt temperature is 215–235°C, mold temperature is 15–25°C, injection velocity is 150–250 mm/s, and holding pressure is 35–45 MPa. At -20°C cold-chain storage, notched Izod impact of homopolymer PP can approach 2.5 kJ/m² per ISO 180:2023; therefore bosses and snap arms in frozen diagnostic kits must have radii greater than 0.50 mm or be assembled after thawing. Nucleating agent is used at 0.05–0.10 wt%, and the processing antioxidant is kept at 0.08–0.12 wt%; internal surfaces of reagent flow paths are molded without erucamide to preserve capillary wetting. Compliance is verified against REACH Regulation (EC) No 1907/2006 Article 33 and RoHS Directive 2011/65/EU. Terminal products are lateral flow cassette housings, microfluidic chip holders, and ELISA plate frames.

    Migration Testing Governs Drug-Contact Packaging

    Solid oral dosage packaging closures, tablet vial bases, and desiccant canister bodies are injection molded from PP1605MED for direct contact with dry pharmaceutical products. The resin is supported by a dual regulatory platform: FDA 21 CFR 177.1520(c) 2.1 for homopolymer polypropylene in food contact, and Commission Regulation (EU) No 10/2011 with an overall migration limit of ≤10 mg/dm² under food contact conditions. For pharmaceutical packaging, extractables testing is performed per USP <1663> and leachables evaluation per USP <1664> where the dosage form may contact the closure system. Melt temperature is 225–245°C in a two-stage injection molding cell or injection blow molding unit; cooling time for a 2.0 mm wall is 8–12 s at mold temperature 15–25°C. Colorants are limited to pharmaceutical-grade masterbatches at 1.0–2.0 wt%; the use of post-consumer recycled material is excluded from drug-contact layers unless a functional barrier and regulatory approval exist. Terminal products are 33 mm and 38 mm child-resistant tablet bottle closures, desiccant canister bodies, and unit-dose container bases.

    Table 2: Normative and regulatory documents for PP1605MED medical and drug-contact applications.

    DocumentScopeTypical acceptance criterion
    FDA 21 CFR 177.1520(c) 2.1Homopolymer polypropylene for food-contact articlesConforms as olefin polymer
    USP <88> Class VIBiological reactivity of plasticsNo systemic toxicity from extracts
    ISO 10993-5:2009Cytotoxicity by L929 cellsGrade 0 or 1
    ISO 10993-10:2021Skin sensitizationNo sensitization response
    ISO 11137-2:2013Radiation sterilization dose validation25 kGy typical device dose
    USP <661.1>Plastic packaging systemsDefined extractables profile
    EU Regulation No 10/2011Plastic food-contact migrationOverall migration ≤10 mg/dm²
    RoHS 2 2011/65/EURestricted substances≤0.1 wt% per homogeneous material
    Free Quote

    Competitive ExxonMobil PP Homopolymer PP1605MED prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please contact us at +8618136850665 or mail to admin@ascent-chem.com.

    We will respond to you as soon as possible.

    Tel: +8618136850665

    Email: admin@ascent-chem.com

    Inquiry

    Get Free Quote of Ascent Petrochem Holdings Co., Limited

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    The management of tight dimensional tolerances in thin-wall, multi-cavity tooling demands a polymer matrix that exhibits controlled crystallisation kinetics under rapid cooling yet maintains sufficient melt fluidity to prevent short shots at filling pressures below 1,200 bar. ExxonMobil PP Homopolymer PP1605MED addresses this regime through a melt mass-flow rate (MFR) of 16 g/10 min when measured per ISO 1133-1:2022 at 230 °C / 2.16 kg, a value calibrated to balance fast injection velocities against the risk of jetting in unrestricted gate designs. Batch-to-batch MFR variation is held within ±1.0 g/10 min across production lots originating from the proprietary Spheripol™ loop-reactor platform, a consistency parameter essential for validated medical device master files that cannot tolerate uncontrolled viscosity drift.

    What Differentiates Homopolymer Morphology in Radiation-Stabilised Grades?

    Where ethylene-propylene random copolymers trade stiffness for impact resistance through secondary comonomer insertion, PP1605MED relies exclusively on isotactic polypropylene chains with a controlled isotactic pentad fraction exceeding 95 %. The absence of ethylene sequences eliminates amorphous domains that preferentially oxidise under gamma exposure, a mechanism responsible for post-sterilisation yellowing and embrittlement observed in copolymer grades stored beyond 12 months. Tensile yield strength measured in accordance with ASTM D638-14 at 50 mm/min reaches 34 MPa on injection-moulded type I dog-bone specimens conditioned at 23 ± 2 °C and 50 ± 10 % relative humidity for 88 h. Retention of this value after a nominal absorbed dose of 25 kGy typically exceeds 92 %, a finding corroborated by carbonyl index change limited to ΔCI < 0.05 when assessed via FTIR-ATR at 1,718 cm⁻¹.

    Regulatory Clearance Matrix

    Evidence of biocompatibility rests on a multi-standard dossier rather than a single certification. The grade holds a Drug Master File (type III) registration with the U.S. FDA, while extractables testing under ISO 10993-12:2021 clause 10.3.2 (exhaustive extraction with isopropanol and hexane) has demonstrated volatile residue below 0.05 mg/dm². Cytotoxicity assessments follow ISO 10993-5:2009 using L929 murine fibroblasts with elution dilutions to 1× MEM; haemolysis index records below 1 % when tested per ASTM F756-17 direct-contact protocol with citrated human blood. Production line quality control further requires compliance with European Pharmacopoeia monograph 3.1.3 (Polyolefins) and USP <88> Biological Reactivity Tests, Class VI, for systemic injection, intracutaneous, and implantation endpoints. A full audit of these conformance documents is summarised in the table below.

    Compliance and test method summary for PP1605MED
    StandardTest DescriptionAcceptance Criterion
    ISO 10993-5Cytotoxicity (L929, MEM elution)Grade 0–1 reactivity
    ISO 10993-10Skin sensitisation (GPMT, guinea pig)No erythema/oedema response
    ISO 10993-11Acute systemic toxicity (saline/CSO extracts)No mortality or pyrexia
    USP <87>Biological reactivity (agar diffusion)Non-cytotoxic
    USP <88>Biological reactivity (in vivo, Class VI)Meets all Class VI limits
    Ph. Eur. 3.1.3Appearance, acidity, heavy metals, residueConforms to current edition
    REACH (EC) 1907/2006Full registration, SVHC screeningNo SVHC >0.1% w/w

    Processability Window in High-Cavitation Tooling

    Moulding operations on 48- to 128-cavity hot-runner systems require a flat viscosity profile across the shear range encountered during cavity filling. Capillary rheometry conducted at 230 °C on a Göttfert RG20 instrument shows a shear-thinning exponent (power-law index) of n = 0.38 between apparent shear rates of 100 s⁻¹ and 5,000 s⁻¹. This pronounced shear thinning permits a pressure drop reduction of approximately 18 % compared with a nominal 12 MFR homopolymer under identical gating conditions. Processing on hydraulic toggle-clamp machines with a clamp force of 1,000–2,500 kN establishes a melt temperature corridor of 220–250 °C; excursions above 260 °C, sustained for over 10 minutes residence time in the barrel, generate oxidative gels visible as black specks in transparent-wall applications. No drying is mandated for sealed-container material at ambient storage, though exposure of opened gaylords to relative humidity exceeding 60 % for more than 4 hours necessitates a desiccant-dryer setpoint of 80 °C for 2 hours to prevent splay on part surfaces.

    Shrinkage anisotropy constitutes the primary dimension-control risk in this formulation. Parallel-to-flow linear shrinkage, measured on 60 × 60 × 2 mm plaques moulded with an edge gate, reads 1.2–1.5 %; perpendicular shrinkage is 1.5–1.8 %, both recorded after 24 h post-demoulding at 23 °C. This difference drives warpage in non-symmetric geometries unless compensated by tool design incorporating a draft angle minimum of 0.5° on ribs. Multi-day moulding campaigns witness a drift in cycle time of +0.3 s for every 10 °C rise in cooling-water inlet temperature above 12 °C, so dedicated chiller capacity delivering 8–12 °C water at a Reynolds number exceeding 10,000 in the mould channels is standard practice.

    Post-moulding crystallinity develops rapidly. Wide-angle X-ray scattering data recorded 30 min after ejection indicates an α-crystal phase content of 48–52 %, which stabilises after 4 h to a terminal crystallinity near 58 %. This rapid phase completion allows dimension verification on vision-inspection lanes within 4 h of production without measurement drift, a logistical advantage over grades that require overnight incubation.

    When Gamma Irradiation Replaces Ethylene Oxide Sterilization

    Single-use syringes and pipette tips subjected to 25–50 kGy Co-60 gamma irradiation rely on the absence of peroxide-body decomposition that would otherwise release low-molecular-weight fragments migrating into aqueous media. PP1605MED, formulated without phenolic antioxidant packages that discolour under radiation, maintains a Yellowness Index increment of less than 4.0 (ASTM E313-20, D65 illuminant, 10° observer) at 25 kGy. At the higher sterilisation dose of 50 kGy, tensile elongation at yield decreases by no more than 15 % relative to unirradiated controls, a boundary condition that remains within the safety margin of devices having a yield-point gauge section. Published data for this specific configuration confirms that Charpy notched impact strength (ISO 179-1/1eA, 23 °C) moves from 3.5 kJ/m² to approximately 2.8 kJ/m² post-25 kGy, a shift traceable to chain scission in the amorphous interlamellar regions. Devices requiring ductile failure modes under drop-impact loading, such as evacuated blood-collection tube closures, are accordingly designed with a minimum wall of 1.2 mm rather than the sub-millimetre dimensions viable in non-sterile isotactic homopolymer parts.

    Comparative Stiffness and Creep Resistance: PP1605MED vs. Random Copolymer Grades

    Flexural modulus determined by ISO 178:2019 at a crosshead speed of 2 mm/min on 80 × 10 × 4 mm bars yields 1,450 MPa for PP1605MED. In comparison, a typical medical-grade random copolymer with comparable MFR exhibits a flexural modulus below 1,050 MPa. This 38 % stiffness differential translates directly into a reduction in deflection under constant load. Creep experiments performed at 40 °C under 10 MPa flexural stress for 1,000 h indicate a creep modulus of 920 MPa for the homopolymer versus 580 MPa for the random copolymer, demonstrating resistance to time-dependent strain that is critical for Luer-lock fittings where interference-fit retention must survive shelf lives exceeding 5 years. The thermal deflection temperature under load (HDT/B, 0.45 MPa, flatwise) registers at 97 °C, permitting exposure to brief vapour-phase hydrogen peroxide sterilisation cycles peaking at 55 °C without dimensional reversion.

    The stiffness advantage must be weighed against the grade’s inherent limitation in low-temperature impact resistance. Whereas random copolymers maintain ductile behaviour at −30 °C, PP1605MED undergoes a ductile-to-brittle transition in the vicinity of 0–5 °C when evaluated by instrumented falling-dart impact at 2.2 m/s. This restricts unmoderated use in devices subjected to sub-zero transport, unless impact modifiers are compounded downstream—an operation that requires requalification of the complete formulation for extractables and leachables under the new additive profile.

    Differences from Fractional-Melt and High-Fluidity Homopolymer Grades

    Within the ExxonMobil medical polypropylene portfolio, PP1605MED occupies a mid-flow position distinct from lower-MFR grades such as PP9074MED (MFR ~24 g/10 min, random copolymer) and higher-MFR homopolymers that can exceed 50 g/10 min. The 16 MFR selection avoids drooling at hot-tip bushings when cycle times extend beyond 15 s, a documented problem with ultra-high-flow homopolymers in vertically gated multi-plate tools. In injection blow-moulding operations for ophthalmic dropper bottles, PP1605MED provides a parison melt strength sufficient to sustain a hang-stretch ratio of 3:1 without premature sag, while still filling the blow-mould cavity at a blow pressure of 0.6 MPa without localised thinning below 0.3 mm. Attempts to process fractional-melt (MFR ≤ 3) homopolymers in the same tooling invariably produce flow hesitation marks and incomplete replication of fine-engraved graduation markings.

    Opacity regulations for radiation indicator labels are met with a 2 mm plaque luminous transmittance of <45 % at 550 nm, sufficient to obscure visual verification of tube content while still permitting inspection via back-lit vision systems. The opacity arises from spherulite boundary scattering and does not require TiO₂ loading, which simplifies the trace-metal profile required by ICH Q3D elemental impurity guidelines for drug packaging. In contrast, transparent copolymer grades achieve >85 % transmittance, a property unnecessary for solid-barrel syringe applications and one that introduces complexity in laser-mark contrast ratios.

    A second table captures the primary thermomechanical values governing tool design, process establishment, and device performance specifications.

    Typical physical and mechanical property values (dry-as-moulded)
    PropertyMethodValue
    Melt mass-flow rateISO 1133-1 (230 °C, 2.16 kg)16 g/10 min
    DensityISO 1183-10.900 g/cm³
    Tensile yield stressASTM D638 (50 mm/min)34 MPa
    Tensile elongation at yieldASTM D6389 %
    Flexural modulusISO 1781,450 MPa
    Charpy notched impact strength (23 °C)ISO 179-1/1eA3.5 kJ/m²
    Rockwell hardnessISO 2039-2 (R-scale)100
    HDT/B (0.45 MPa)ISO 75-297 °C
    Vicat softening point (10 N)ISO 306153 °C
    Mould shrinkage (parallel)ISO 294-41.2–1.5 %

    Incompatibility warnings issued by ExxonMobil Product Stewardship note that the resin must not be blended with copper-based heat stabilisers or with post-industrial recyclate streams containing polyamide contamination, as amide hydrolysis products catalytically degrade the isotactic backbone at processing temperatures. Storage in direct ultraviolet light — as opposed to ambient fluorescent factory lighting — shortens the viable shelf-life of the irradiated grade to 3 years from the date of manufacture, after which brakedown indexes measurable by FTIR begin to approach action thresholds for clinical distribution. No material adjustment factor is provided for electron-beam sterilisation, although studies on analogous isotactic homopolymers suggest similar radical recombination pathways operate at 10 MeV beam energies.

    On twin-screw compounding lines (co-rotating, L/D = 40) used for pre-colouring with masterbatch, the recommended dosage of pigment carrier does not exceed 2.0 wt% at a screw speed of 300 min⁻¹ to avoid excessive shear-induced chain scission that manifests as a downward drift in MFR beyond the grade’s specified window. Screw configurations employing distributive mixing elements in the final two zones generate a pressure-absorption profile that reduces the discharge temperature to 215–225 °C, preserving the additive package and stabilising the colour-deviation metric (ΔE*ab) below 0.6 across a production shift of 8 h.

    The formulation is designed to meet the elution demands of aqueous parenteral preparation containers defined by USP <661.1> plastic packaging systems, with total organic carbon (TOC) in purified water extract held at less than 100 µg/L after 70 °C / 24 h accelerated extraction. Published data for this specific configuration is limited when evaluating excursions into lipid-rich alternative drug delivery vehicles, and therefore preliminary compatibility testing per ICH Q8(R2) risk-assessment frameworks is mandatory before selecting PP1605MED for a novel primary-packaging container-closure system.

    Injection stretch-blow moulding trials performed on a single-stage Aoki SBIII-100LL-20 station documented that the grade’s stretch-hardening modulus, recorded during simultaneous biaxial extension at a Hencky strain of 2.0 and a rate of 1.0 s⁻¹, reaches 22 MPa. This value is sufficient to prevent sidewall buckling in biaxially oriented containers with a stretch ratio of 2.5 × 1.8, provided that the preform temperature is homogenised using infrared pyrometer zone-control loops having a setpoint tolerance of ±3 °C. Higher deviations induce localised necking that appears as faint horizontal banding on the container sidewall under polarised light inspection, a cosmetic defect that does not affect burst-pressure capability but triggers rejection under automated AQL sampling plans.

    Top